09 February 2024>: Articles
Recurrent Var. Bacteremia and Review of the Literature on : The First Case Report
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease
Kazuhiro Ishikawa A , Ryo Hasegawa A , Keitaro Furukawa C , Fujimi Kawai A , Yuki Uehara A , Kiyofumi Ohkusu C , Nobuyoshi Mori A*DOI: 10.12659/AJCR.942553
Am J Case Rep 2024; 25:e942553
Table 1. Susceptibility panel.
MIC | Susceptibility | MIC | Susceptibility | ||
---|---|---|---|---|---|
PCG | ≤0.06 | S | EM | ≤0.5 | S |
CEZ | ≤8 | S | CLDM | ≤0.5 | S |
CTRX | ≤8 | S | MINO | ≤4 | S |
IMP/CS | ≤0.5 | S | LVFX | ≤1 | S |
GM | ≤4 | S | |||
* Interpretation (susceptible, intermediate, or resistant) was based on the Clinical and Laboratory Standards Institute (CLSI) criteria (M45). For other antimicrobials, the breakpoints for spp. in the CLSI guidelines M 100-S22 and S24 were used according to the previous study []. PCG – penicillin G; CEZ – cefazoline; CTRX – ceftriaxone; IPM/CS – imipenem/cilastatin; EM – erythromycin; GM – gentamycin; CLDN – clindamycin; MINO – minocycline; LVFX – levofloxacin; MIC – minimum inhibitory concentration; S – susceptible. |